Compile Data Set for Download or QSAR
maximum 50k data
Found 35 with Last Name = 'godek' and Initial = 'dm'
TargetSigma intracellular receptor 2(Homo sapiens (Human))
Medisynergics

US Patent
LigandPNGBDBM497388(US11007200, Example 4a | US11426411, Example 4a)
Affinity DataKi:  15.5nMAssay Description:Ki determinations were generously provided by the National Institute of Mental Health's Psychoactive Drug Screening Program (PDSP).More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSigma intracellular receptor 2(Homo sapiens (Human))
Medisynergics

US Patent
LigandPNGBDBM497388(US11007200, Example 4a | US11426411, Example 4a)
Affinity DataKi:  15.5nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSigma non-opioid intracellular receptor 1(Homo sapiens (Human))
Medisynergics

US Patent
LigandPNGBDBM497384(US11007200, Example 2a | US11426411, Example 2a)
Affinity DataKi:  17.3nMAssay Description:Ki determinations were generously provided by the National Institute of Mental Health's Psychoactive Drug Screening Program (PDSP).More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSigma non-opioid intracellular receptor 1(Homo sapiens (Human))
Medisynergics

US Patent
LigandPNGBDBM497384(US11007200, Example 2a | US11426411, Example 2a)
Affinity DataKi:  17.3nMAssay Description:Procedures employed by the PDSP as described in the NIMH-PDSP Assay Protocol Book, Version II. The standard drug used in both Sigma subtype assays is...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSigma intracellular receptor 2(Homo sapiens (Human))
Medisynergics

US Patent
LigandPNGBDBM497386(US11007200, Example 3a | US11426411, Example 3a)
Affinity DataKi:  18nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSigma intracellular receptor 2(Homo sapiens (Human))
Medisynergics

US Patent
LigandPNGBDBM497386(US11007200, Example 3a | US11426411, Example 3a)
Affinity DataKi:  18nMAssay Description:Ki determinations were generously provided by the National Institute of Mental Health's Psychoactive Drug Screening Program (PDSP).More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetKappa-type opioid receptor(Homo sapiens (Human))
Medisynergies

US Patent
LigandPNGBDBM247007(US9700563, 4)
Affinity DataKi:  30nMAssay Description:The compounds were tested for activity vs. opioid receptor subtypes Kappa (KOR), Delta (DOR) and Mu (MOR) at an initial concentration of 10 μM e...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSigma non-opioid intracellular receptor 1(Homo sapiens (Human))
Medisynergics

US Patent
LigandPNGBDBM497386(US11007200, Example 3a | US11426411, Example 3a)
Affinity DataKi:  35.4nMAssay Description:Procedures employed by the PDSP as described in the NIMH-PDSP Assay Protocol Book, Version II. The standard drug used in both Sigma subtype assays is...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSigma non-opioid intracellular receptor 1(Homo sapiens (Human))
Medisynergics

US Patent
LigandPNGBDBM497386(US11007200, Example 3a | US11426411, Example 3a)
Affinity DataKi:  35.4nMAssay Description:Ki determinations were generously provided by the National Institute of Mental Health's Psychoactive Drug Screening Program (PDSP).More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSigma non-opioid intracellular receptor 1(Homo sapiens (Human))
Medisynergics

US Patent
LigandPNGBDBM568457(US11426411, Example 2b)
Affinity DataKi:  37.2nMAssay Description:Ki determinations were generously provided by the National Institute of Mental Health's Psychoactive Drug Screening Program (PDSP).More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSigma non-opioid intracellular receptor 1(Homo sapiens (Human))
Medisynergics

US Patent
LigandPNGBDBM497391(US11007200, Example 2b)
Affinity DataKi:  37.2nMAssay Description:Procedures employed by the PDSP as described in the NIMH-PDSP Assay Protocol Book, Version II. The standard drug used in both Sigma subtype assays is...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetKappa-type opioid receptor(Homo sapiens (Human))
Medisynergies

US Patent
LigandPNGBDBM247009(US9700563, 7)
Affinity DataKi:  47nMAssay Description:The compounds were tested for activity vs. opioid receptor subtypes Kappa (KOR), Delta (DOR) and Mu (MOR) at an initial concentration of 10 μM e...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSigma intracellular receptor 2(Homo sapiens (Human))
Medisynergics

US Patent
LigandPNGBDBM497384(US11007200, Example 2a | US11426411, Example 2a)
Affinity DataKi:  59.8nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSigma intracellular receptor 2(Homo sapiens (Human))
Medisynergics

US Patent
LigandPNGBDBM497384(US11007200, Example 2a | US11426411, Example 2a)
Affinity DataKi:  59.8nMAssay Description:Ki determinations were generously provided by the National Institute of Mental Health's Psychoactive Drug Screening Program (PDSP).More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSigma non-opioid intracellular receptor 1(Homo sapiens (Human))
Medisynergics

US Patent
LigandPNGBDBM497390(US11007200, Example 13a | US11426411, Example 13a)
Affinity DataKi:  70nMAssay Description:Procedures employed by the PDSP as described in the NIMH-PDSP Assay Protocol Book, Version II. The standard drug used in both Sigma subtype assays is...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSigma non-opioid intracellular receptor 1(Homo sapiens (Human))
Medisynergics

US Patent
LigandPNGBDBM497390(US11007200, Example 13a | US11426411, Example 13a)
Affinity DataKi:  70nMAssay Description:Ki determinations were generously provided by the National Institute of Mental Health's Psychoactive Drug Screening Program (PDSP).More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSigma non-opioid intracellular receptor 1(Homo sapiens (Human))
Medisynergics

US Patent
LigandPNGBDBM497388(US11007200, Example 4a | US11426411, Example 4a)
Affinity DataKi:  97.2nMAssay Description:Ki determinations were generously provided by the National Institute of Mental Health's Psychoactive Drug Screening Program (PDSP).More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSigma non-opioid intracellular receptor 1(Homo sapiens (Human))
Medisynergics

US Patent
LigandPNGBDBM497388(US11007200, Example 4a | US11426411, Example 4a)
Affinity DataKi:  97.2nMAssay Description:Procedures employed by the PDSP as described in the NIMH-PDSP Assay Protocol Book, Version II. The standard drug used in both Sigma subtype assays is...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSigma intracellular receptor 2(Homo sapiens (Human))
Medisynergics

US Patent
LigandPNGBDBM497390(US11007200, Example 13a | US11426411, Example 13a)
Affinity DataKi:  98nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSigma intracellular receptor 2(Homo sapiens (Human))
Medisynergics

US Patent
LigandPNGBDBM497390(US11007200, Example 13a | US11426411, Example 13a)
Affinity DataKi:  98nMAssay Description:Ki determinations were generously provided by the National Institute of Mental Health's Psychoactive Drug Screening Program (PDSP).More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSigma non-opioid intracellular receptor 1(Homo sapiens (Human))
Medisynergics

US Patent
LigandPNGBDBM497392(US11007200, Example 13b | US11426411, Example 13b)
Affinity DataKi:  146nMAssay Description:Procedures employed by the PDSP as described in the NIMH-PDSP Assay Protocol Book, Version II. The standard drug used in both Sigma subtype assays is...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSigma non-opioid intracellular receptor 1(Homo sapiens (Human))
Medisynergics

US Patent
LigandPNGBDBM497392(US11007200, Example 13b | US11426411, Example 13b)
Affinity DataKi:  146nMAssay Description:Ki determinations were generously provided by the National Institute of Mental Health's Psychoactive Drug Screening Program (PDSP).More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSigma non-opioid intracellular receptor 1(Homo sapiens (Human))
Medisynergics

US Patent
LigandPNGBDBM497387(US11007200, Example 3b | US11426411, Example 3b)
Affinity DataKi:  217nMAssay Description:Procedures employed by the PDSP as described in the NIMH-PDSP Assay Protocol Book, Version II. The standard drug used in both Sigma subtype assays is...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSigma non-opioid intracellular receptor 1(Homo sapiens (Human))
Medisynergics

US Patent
LigandPNGBDBM497387(US11007200, Example 3b | US11426411, Example 3b)
Affinity DataKi:  217nMAssay Description:Ki determinations were generously provided by the National Institute of Mental Health's Psychoactive Drug Screening Program (PDSP).More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetKappa-type opioid receptor(Homo sapiens (Human))
Medisynergies

US Patent
LigandPNGBDBM247008(US9700563, 6)
Affinity DataKi:  249nMAssay Description:The compounds were tested for activity vs. opioid receptor subtypes Kappa (KOR), Delta (DOR) and Mu (MOR) at an initial concentration of 10 μM e...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSigma intracellular receptor 2(Homo sapiens (Human))
Medisynergics

US Patent
LigandPNGBDBM568457(US11426411, Example 2b)
Affinity DataKi:  305nMAssay Description:Ki determinations were generously provided by the National Institute of Mental Health's Psychoactive Drug Screening Program (PDSP).More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSigma intracellular receptor 2(Homo sapiens (Human))
Medisynergics

US Patent
LigandPNGBDBM497391(US11007200, Example 2b)
Affinity DataKi:  305nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSigma intracellular receptor 2(Homo sapiens (Human))
Medisynergics

US Patent
LigandPNGBDBM497389(US11007200, Example 4b | US11426411, Example 4b)
Affinity DataKi:  426nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSigma intracellular receptor 2(Homo sapiens (Human))
Medisynergics

US Patent
LigandPNGBDBM497389(US11007200, Example 4b | US11426411, Example 4b)
Affinity DataKi:  426nMAssay Description:Ki determinations were generously provided by the National Institute of Mental Health's Psychoactive Drug Screening Program (PDSP).More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSigma intracellular receptor 2(Homo sapiens (Human))
Medisynergics

US Patent
LigandPNGBDBM497392(US11007200, Example 13b | US11426411, Example 13b)
Affinity DataKi:  435nMAssay Description:Ki determinations were generously provided by the National Institute of Mental Health's Psychoactive Drug Screening Program (PDSP).More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSigma intracellular receptor 2(Homo sapiens (Human))
Medisynergics

US Patent
LigandPNGBDBM497392(US11007200, Example 13b | US11426411, Example 13b)
Affinity DataKi:  435nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSigma intracellular receptor 2(Homo sapiens (Human))
Medisynergics

US Patent
LigandPNGBDBM497387(US11007200, Example 3b | US11426411, Example 3b)
Affinity DataKi:  675nMAssay Description:Ki determinations were generously provided by the National Institute of Mental Health's Psychoactive Drug Screening Program (PDSP).More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSigma intracellular receptor 2(Homo sapiens (Human))
Medisynergics

US Patent
LigandPNGBDBM497387(US11007200, Example 3b | US11426411, Example 3b)
Affinity DataKi:  675nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSigma non-opioid intracellular receptor 1(Homo sapiens (Human))
Medisynergics

US Patent
LigandPNGBDBM497389(US11007200, Example 4b | US11426411, Example 4b)
Affinity DataKi:  697nMAssay Description:Procedures employed by the PDSP as described in the NIMH-PDSP Assay Protocol Book, Version II. The standard drug used in both Sigma subtype assays is...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSigma non-opioid intracellular receptor 1(Homo sapiens (Human))
Medisynergics

US Patent
LigandPNGBDBM497389(US11007200, Example 4b | US11426411, Example 4b)
Affinity DataKi:  697nMAssay Description:Ki determinations were generously provided by the National Institute of Mental Health's Psychoactive Drug Screening Program (PDSP).More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent